ATE545419T1 - Famciclovir zur behandlung von rezidivierendem herpes labialis mittels einmal-täglich-behandlung - Google Patents

Famciclovir zur behandlung von rezidivierendem herpes labialis mittels einmal-täglich-behandlung

Info

Publication number
ATE545419T1
ATE545419T1 AT06739956T AT06739956T ATE545419T1 AT E545419 T1 ATE545419 T1 AT E545419T1 AT 06739956 T AT06739956 T AT 06739956T AT 06739956 T AT06739956 T AT 06739956T AT E545419 T1 ATE545419 T1 AT E545419T1
Authority
AT
Austria
Prior art keywords
treatment
famciclovir
once
herpes labialis
recurrent herpes
Prior art date
Application number
AT06739956T
Other languages
German (de)
English (en)
Inventor
Stephan Billstein
Robert Charnas
Spotswood Spruance
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Priority claimed from PCT/US2006/011498 external-priority patent/WO2006105216A1/en
Application granted granted Critical
Publication of ATE545419T1 publication Critical patent/ATE545419T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06739956T 2005-03-30 2006-03-29 Famciclovir zur behandlung von rezidivierendem herpes labialis mittels einmal-täglich-behandlung ATE545419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66653605P 2005-03-30 2005-03-30
PCT/US2006/011498 WO2006105216A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Publications (1)

Publication Number Publication Date
ATE545419T1 true ATE545419T1 (de) 2012-03-15

Family

ID=36829888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06739956T ATE545419T1 (de) 2005-03-30 2006-03-29 Famciclovir zur behandlung von rezidivierendem herpes labialis mittels einmal-täglich-behandlung

Country Status (15)

Country Link
US (4) US20100298353A1 (enExample)
EP (2) EP2363131A1 (enExample)
JP (3) JP2008534603A (enExample)
KR (1) KR101312820B1 (enExample)
CN (1) CN101678028A (enExample)
AT (1) ATE545419T1 (enExample)
AU (3) AU2006230269A1 (enExample)
BR (1) BRPI0609793A2 (enExample)
CA (1) CA2602641A1 (enExample)
ES (1) ES2382664T3 (enExample)
PL (1) PL1865961T3 (enExample)
PT (1) PT1865961E (enExample)
RU (2) RU2007139762A (enExample)
TW (1) TW200716124A (enExample)
WO (1) WO2006105194A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
RU2179849C2 (ru) * 1999-07-27 2002-02-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения рецидивирующего генитального герпеса у женщин
RU2178699C1 (ru) * 2001-04-04 2002-01-27 Змызгова Анна Васильевна Способ лечения герпесовирусных инфекций, включающий озонотерапию
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Also Published As

Publication number Publication date
AU2010201834A1 (en) 2010-05-27
US20100298353A1 (en) 2010-11-25
US20120329814A1 (en) 2012-12-27
JP2013049687A (ja) 2013-03-14
KR101312820B1 (ko) 2013-09-27
KR20080004535A (ko) 2008-01-09
JP2008534603A (ja) 2008-08-28
RU2007139762A (ru) 2009-05-10
AU2006230291A8 (en) 2013-10-24
PL1865961T3 (pl) 2012-07-31
WO2006105194A2 (en) 2006-10-05
EP2363131A1 (en) 2011-09-07
EP1865961B1 (en) 2012-02-15
RU2007139758A (ru) 2009-05-10
WO2006105194A3 (en) 2006-12-21
RU2432951C2 (ru) 2011-11-10
BRPI0609793A2 (pt) 2010-04-27
JP2015163614A (ja) 2015-09-10
AU2006230269A1 (en) 2006-10-05
US20150005324A1 (en) 2015-01-01
AU2006230291A1 (en) 2006-10-05
TW200716124A (en) 2007-05-01
PT1865961E (pt) 2012-05-22
CA2602641A1 (en) 2006-10-05
ES2382664T3 (es) 2012-06-12
JP6018473B2 (ja) 2016-11-02
CN101678028A (zh) 2010-03-24
US20120088781A1 (en) 2012-04-12
AU2010201834B2 (en) 2012-04-19
EP1865961A1 (en) 2007-12-19

Similar Documents

Publication Publication Date Title
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
EP1755661A4 (en) USE OF GELSOLINE FOR THE TREATMENT OF INFECTIONS
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
AR058182A1 (es) Metodos, composiciones y equipos par el tratamiento de afecciones medicas
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
BRPI0511111A (pt) compostos de pirrol como inibidores de cinase de proteìna de erk, sua sìntese e seus intermediários
DE602005001929D1 (de) Sulfonamidderivate zur behandlung von krankheiten
CY1110162T1 (el) Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας
CY1114735T1 (el) Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5
EA201000866A1 (ru) Производные амидов 6,7-дигидро-5н-имидазо[1,2-а]имидазол-3-карбоновой кислоты
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
NO20076241L (no) Terapier for vaskulaere sykdommer
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
EA200602002A1 (ru) Применение спинозинов для заживления ран
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии